SCHEMBL7985108

SCHEMBL7985108

NC(=O)c1c(NC(=O)c2cccnc2)ncn1CCCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.52
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 3/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
ALOX15 P16050 1/20 0.45
LMNA P02545 5/20 0.44
SIRT2 Q8IXJ6 2/20 0.44
SIRT1 Q96EB6 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
MAPT P10636 2/20 0.42
MAPK1 P28482 2/20 0.42
USP2 O75604 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ADORA3 P0DMS8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988677 0.95 SMN1; SMN2 (0.51) EPHX2KMT2ASMN1; SMN2MEN1RAB9A
SCHEMBL7984506 0.91 EHMT2 (0.43) SMN1; SMN2RAB9ANPC1SIRT2SIRT1
SCHEMBL7991860 0.85 ADORA2A (0.46) KMT2ASMN1; SMN2MEN1RAB9ANPC1
SCHEMBL7973823 0.84 NPC1 (0.48) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL7988686 0.83 NPC1 (0.47) KMT2ASMN1; SMN2MEN1RAB9ANPC1
SCHEMBL7987763 0.80 RAB9A (0.44) KMT2ASMN1; SMN2MEN1RAB9ANPC1
SCHEMBL7974138 0.79 KMT2A (0.52) KMT2ASMN1; SMN2MEN1RAB9ANPC1
SCHEMBL7984889 0.79 NPC1 (0.46) KMT2ASMN1; SMN2MEN1RAB9ANPC1
SCHEMBL7974555 0.79 HDAC1 (0.45) EPHX2KMT2ASMN1; SMN2MEN1RAB9A
SCHEMBL7992620 0.78 NPC1 (0.53) KMT2ASMN1; SMN2MEN1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed